SLC22A12 is DE between KIRC tumors and normal kidney, associated with overall survival in KIRC and DE between tumor size and progression (T3 vs. T4, Figure 3A), stage I v II, and presence of metastasis (M0 vs. M1, Figure 3B). The gene discussed is SLC22A12; the disease is neoplasm.